Botulinum Toxin

World Market Report

MCP-1833

EXECUTIVE ENGAGEMENTS

POOL

702
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

142
Interactions with Platform & by Email

PARTICIPANTS

28
Unique # Participated

VALIDATIONS

11
Responses Validated*

COMPANIES

28
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

201

PAGES

353

EDITION

20

PRICE

USD 5600

CODE

MCP-1833


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Botulinum Toxin Market to Reach $8.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Botulinum Toxin estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$8.5 Billion by 2027, growing at aCAGR of 8.2% over the period 2020-2027. Type A, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$8.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Type B segment is readjusted to a revised 6.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 14.8% CAGR
The Botulinum Toxin market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$762.1 Million by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 6.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

SELECT PLAYERS

AbbVie; Daewoong Pharmaceutical Co., Ltd.; HUGEL Pharma; Ipsen Group; Medy-Tox Inc.; Merz Pharma GmbH & Co. KGaA; Metabiologics, Inc.; Revance Therapeutics, Inc.; US WorldMeds

SEGMENTS

» Product (Type A, Type B) » Application (Therapeutics, Aesthetics) » End-Use (Specialty & Dermatology Clinics, Hospitals & Clinics, Other End-Uses)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Disruptions Impact Botulinum Toxin Business
Virtual Care to the Fore amid COVID-19
Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID‐19 Infection Transmission
EXHIBIT: % Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020
COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions
Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection
Botulinum Toxin – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Botulinum Toxin: An Introduction
Outlook
Therapeutic BTX Applications Lead
Cosmetic BTX Gradually Gains Momentum
Factors Propelling the Cosmetic BT Market: In a Nut Shell
EXHIBIT: Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019
Developed Regions Dominate Botulinum Toxin Market
Developing Markets to Drive Future Growth
Competitive Landscape
Intense Competition Characterizes Botulinum Toxin Market
EXHIBIT: Market Share of Leading Players in Global Botulinum Toxin Market: 2019
Select Approved Botulinum Toxin Products Worldwide
Companies Entering the Fray
Pharma Companies Eye Lucrative BT Market
Biosimilar BTX Variants Challenge Botox’s Leadership
Lack of Differentiation among Approved BTX Products
Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
BOTOX®
Ipsen Counts on New Indications for Future Growth of Dysport
Xeomin®
Merz
Other Products
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
EXHIBIT: Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes
Botulinum Toxin: The Preferred Solution in Facial Injectables Market
EXHIBIT: Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender
Millennials: A Popular Demographic for Botulinum Toxin
EXHIBIT: Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share
Therapeutic Areas and Opportunities
Botox Therapeutic Applications Uses and Indications
EXHIBIT: Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019)
Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
Rise in the Number of Musculoskeletal Indications: Potential for Growth
Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
Combination Therapies: A Double Whammy Success
Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
Potential Applications in Dentistry
Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
EXHIBIT: Life Expectancy at Birth in Years of People in Select Countries
EXHIBIT: Life Expectancy at Birth (in Years) of Men and Women by Region
Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Challenges and Issues
Undesirable Side Effects: A Challenge to Reckon With
Immunogenicity Undermines Patient Compliance
Antigenicity: A Problematic Issue in Drug Development
Potential Adverse Side Effects: A Major Barrier to Success
Stringent Regulations Delay Market Approvals
Higher Product Costs to Challenge Market Growth
Consumer Skepticism: The Biggest Challenge to Beat
Animal Cruelty:A Part & Parcel of Botox Testing
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
Market Overview
Opportunities in Store for Cosmetic BTX
EXHIBIT: Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019
EXHIBIT: Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019)
Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
Cosmetic Procedures: Facts and Figures
Aging Baby Boomers Drive Aesthetic Business
EXHIBIT: US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups
EXHIBIT: North American Aging Population by Age Group: 1975-2050
Expanding Physician Base Extends Impetus to Growth
Therapeutic BTX Seeks Growth Opportunities
Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
Neurogenic OAB: A Lucrative Market Opportunity
Competitive Landscape
Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market
EXHIBIT: Market Share of Leading Brands in the US Boulinum Toxin Market: 2019
Dysport Poses Strong Competition to Botox in the Therapeutic Space
USA Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Market Overview
EXHIBIT: Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
Uptrend in Facial Injectables Market Favors Market Expansion
Regulatory Scenario
Approved Botulinum Toxin Injections in China
Competition
Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019
China Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
Botox Approvals and Indications in Select European Countries
EXHIBIT: Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type
Regulations for Botulinum Toxin Usage in the EU
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
Market Overview
Snapshots
UK Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
Market Overview
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Market Overview
TABLE: Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Market Overview
EXHIBIT: Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
India Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
Market Overview
Strong Demand for Cosmetic Procedures – Potential for BTX Market
EXHIBIT: Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
EXHIBIT: Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
Competition
Market Share of Leading Players in Botulinum Toxin Market In South Korea
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com